Skip to main content

Table 2 Clinical characteristics of participants with different LVMI changes

From: Prognostic values of left ventricular mass index progression in incident peritoneal dialysis patients : a prospective cohort study

 

Total

LVMI-regression N = 113

Stable N = 31

LVMI-progression N = 72

P value

Age

55.3 ± 16.8

54.2 ± 16.8

60.1 ± 16.4

55. 2 ± 17.0

0.785

Male, n(%)

130(60.2%)

65(57.5%)

18(58.1%)

42(64.6%)

0.557

BMI (kg/m2)

23.1 ± 3.5

22.6 ± 3.3

24.2 ± 3.1

23.7 ± 3.6

0.047

SBP (mmHg)

135 ± 14

134 ± 14

135 ± 15

138 ± 15

0.124

DBP (mmHg)

82 ± 8

81 ± 9

80 ± 8

84 ± 10

0.021

MAP

99.6 ± 9.2

98.3 ± 8.8

98.7 ± 8.3

102.1 ± 9.7

0.018

History of smoking

45(20.8%)

23(20.4%)

8(25.8%)

13(20.0%)

0.754

History of diabetes

53(24.5%)

29(25.7%)

4(12.9%)

20(30.8%)

0.253

Use of statins

42(19.4%)

21(18.6%)

6(19.4%)

15(23.1%)

0.931

Use of anti-hypertensive drugs

200(92.6%)

103(91.2%)

28(90.3%)

69(65.8%)

0.436

Use of RAAS antagonists

93(43.1%)

51(45.1%)

11(35.5%)

30(46.2%)

0.130

Dialysis-related variables

 CAPD, n(%)

202(93.5%)

106(93.8%)

27(87.1%)

69(95.8%)

0.251

 nPCR (g/kg/24 h)

0.93 ± 0.18

0.94 ± 0.17

0.91 ± 0.15

0.92 ± 0.18

0.647

 Urinary output(L/24 h)

0.86(0.50,1.28)

0.83(0.46,1.28)

0.83(0.67, 1.14)

0.92(0.57,1.29)

0.858

 Total Ccr (L/week)

67.5(57.1, 81.8)

67.7(57.5,84.0)

68.2(54.6, 88.7)

66.8(57.4,79.5)

0.733

 Residual renal Ccr (L/week)

31.3(18.9, 46.5)

32.4(20.1,49.6)

30.5(15.5,52.7)

31.2(18.8,42.9)

0.609

 Total Kt/V

1.93(1.72,2.22)

1.94(1.71,2.26)

1.98(1.70,2.16)

1.88(1.73,2.15)

0.539

 Residual renal Kt/V

0.61(0.36, 0.88)

0.61(0.35,0.92)

0.61(0.35,0.88)

0.62(0.42,0.87)

0.984

 Proportion of 1.5%-glucose dialysate(%)

88.9(69.4,100)

88.9(67.8,100)

80.6(66.7,100)

91.7(75.0,100)

0.770

 Volume of dialysate(L/24 h)

6.27(5.82, 7.59)

6.19(5.83,7.53)

6.40(5.92,7.44)

6.30(5.73,7.68)

0.917

Biochemical parameters

 Hemoglobin (g/L)

100.0 ± 13.8

101.8 ± 13.7

99.9 ± 13.7

96.6 ± 13.8

0.055

 Ferritin (ng/ml)

233.1(153.8, 327.3)

256.0(163.7,343.2)

207.1(157.0,267.7)

205.8(138.7,307.3)

0.033

 Serum iron (umol/L)

12.3(10.1, 15.1)

13.3(10.6,15.3)

12.1(10.4,14.5)

11.6(9.2,14.3)

0.129

 Iron saturation (%)

31.7(26.0, 38.0)

32.7(27.3, 39.7)

31.7(27.7, 36.0)

28.3(24.0,34.3)

0.059

 Albumin (g/L)

35.8 ± 4.4

36.3 ± 4.7

34.8 ± 4.2

35.3 ± 4.0

0.184

 Calcium (mmol/L)

2.15 ± 0.17

2.15 ± 0.18

2.16 ± 0.15

2.14 ± 0.14

0.812

 Phosphate (mmol/L)

1.53(1.32, 1.79)

1.56 ± 0.32

1.55 ± 0.36

1.61 ± 0.40

0.513

 iPTH (pg/mL)

284.1(186.6, 393.7)

302.3(203.7,423.3)

208.5(156.4,332.3)

283.8(180.8,388.4)

0.139

 CHO (mmol/L)

4.40 ± 0.91

4.46 ± 0.99

4.22 ± 0.80

4.40 ± 0.83

0.439

 TG (mmol/L)

1.62(1.25, 2.28)

1.64(1.23, 2.57)

1.54(1.32, 2.33)

1.64(1.22, 2.29)

0.994

 LDL (mmol/L)

2.29(1.92, 2.71)

2.25(1.88,2.73)

2.29(1.74,2.59)

2.32(2.08,2.70)

0.311

 HDL (mmol/L)

0.94(0.80, 1.12)

0.97(0.84,1.15)

0.84(0.76,1.03)

0.90(0.77,1.09)

0.036

 ApoA1 (g/L)

0.99(0.89, 1.12)

1.01(0.94, 1.15)

0.93(0.86, 1.09)

0.96(0.86, 1.06)

0.009

 ApoB (g/L)

0.69 ± 0.15

0.69 ± 0.16

0.68 ± 0.14

0.70 ± 0.14

0.822

 NT-proBNP (per 1000 pg/ml)

2.26(0.93, 7.47)

1.95(0.80,7.58)

2.28(1.46,5.23)

2.50(1.15,8.93)

0.428

 hsCRP (mg/L)

1.65(0.79, 4.12)

1.33(0.61,3.73)

2.11(1.12,4.40)

1.96(1.12,5.40)

0.032

 FIB (g/L)

3.72(3.26, 4.31)

3.64(3.13,4.13)

3.85(3.34,4.36)

3.88(3.45, 4.59)

0.014